-
Mashup Score: 0
POEMs
Source: www.aafp.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Economic Cost of US Older Adult Assault Injuries - 1 hour(s) ago
This economic evaluation uses nationwide public health data to evaluate incidence and economic costs of homicides and nonfatal assault injuries among US adults aged 60 years or older.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2QOL Benefits With Nivolumab, Challenges with Sacituzumab Govitecan¬ Characterize Bladder Cancer Management Updates - 1 hour(s) ago
Guru Sonpavde, MD, expands on findings from 2 key bladder cancer trials presented at the 2024 ESMO Congress.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
Datopotamab deruxtecan previously showed statistically significant improvement in progression-free survival in patients with HR+, HER2-low, or HER2-negative breast cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Long-term Risk of Right Coronary Artery Injury Following Catheter Ablation of Cavotricuspid Isthmus-dependent Flutter - 1 hour(s) ago
Radiofrequency ablation (RFA) of cavotricuspid isthmus (CTI)-dependent atrial flutter requires ablation of the tricuspid annulus overlying the right coronary artery (RCA). While considered safe, reports of acute and subacute RCA injury in human and animal studies raise the possibility of late RCA stenosis.
Source: www.heartrhythmjournal.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
The designation was based on positive data from the phase 2b FASCINATE trial of denifanstat in noncirrhotic MASH with moderate to advanced fibrosis.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Aptadir Therapeutics Pioneers RNA Inhibitors That Target Hypermethylation in Rare Genetic Disorders - 1 hour(s) ago
Aptadir engineers RNA therapies that inhibit DNMT-1 to prevent methylation in genes associated with myelodysplastic syndrome and other disorders.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0Health Equity Program - 1 hour(s) ago
Class sizes are limited and you must be registered to participate. Please do not share links or class materials with others. See map below for information on where your training region is located. See map below for information on where your training region is located. See map below for information on where your training region is located. We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Source: healthequityprogram.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The FDA has granted traditional approval to selpercatinib (Retevmo) to treat patients 2 years of age and older who have RET-mutant, advanced or metastatic medullary thyroid cancer and require systemic therapy.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention - 1 hour(s) ago
AbstractBackgroundTranscatheter tricuspid valve intervention (TTVI) has been increasingly adopted in recent years for the treatment of patients with tricuspid regurgitation (TR). However, no dedica…
Source: www.jacc.orgCategories: General Medicine News, Partners & KOLsTweet
Does continuous glucose monitoring (CGM) offer a benefit over traditional glucose self-monitoring in patients with type 2 diabetes mellitus? https://t.co/4CtKVq021M #familymedicine #afpjournal #diabetes https://t.co/traxQcHSm5